A study recently carried out by a team of researchers from the University of New Mexico has highlighted the pain-relieving potential of cannabis' psychoactive constituent, tetrahydrocannabinol, A.K.A....
The 2018 U.S. Farm Bill was expected to eliminate the uncertainty that enshrouds the hemp and CBD industries. In spite of it passing with President Donald Trump’s signature in December of last year,...
At the end of last month, leading medical and wellness cannabis operator Curaleaf Holdings Inc. was given a warning by the Food and Drug Administration (FDA) for making false health claims about the CBD-containing...
On Monday, Justin Gover hit a milestone in his career. He is the CEO of GW Pharmaceuticals – a company that created a cannabis-based medicine called Epidiolex. Not only is Epidiolex being used to treat...
Cannabis is listed as a Schedule I narcotic, but things could be about to change. If the plant is moved to Schedule II, medical patients everywhere will rejoice.
But what if the decision to reschedule...
A cannabis-based medication for epilepsy could be the first to gain approval by the Food and Drug Administration (FDA). Created by British company GW Pharmaceuticals, cannabis-based epilepsy treatment...
The Food and Drug Administration sent warning letters to four companies on Tuesday, alerting them they cannot market their cannabis products as a treatment for certain diseases.
The agency warned the...
On Tuesday, Food and Drug Administration (FDA) Commissioner Scott Gottlieb said the agency could begin prosecuting cannabis companies who claim unproven health benefits in their products.
The FDA...
